paclitaxel has been researched along with Adenomatous Polyposis Coli in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appleton, P; Kroboth, K; Nathke, IS; Patel, S; Radulescu, S; Ridgway, RA; Sansom, OJ; Taylor, S; Woodgett, J | 1 |
| Bacon, KD; Crass, RC; Deveney, CW; Deveney, KE; Land, J; Leonetti, PO; Meichsner, CL; Rutten, MJ; Sheppard, BC; Trunkey, DD | 1 |
2 other study(ies) available for paclitaxel and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol.
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Transformation, Neoplastic; Chromosomal Instability; Drug Resistance, Neoplasm; Enterocytes; Male; Mice; Mice, Inbred C57BL; Paclitaxel; Protein Serine-Threonine Kinases; Sequence Deletion; Spindle Apparatus; Vinblastine; Vinorelbine; Wnt Proteins | 2010 |
Effects of paclitaxel on the growth of normal, polyposis, and cancerous human colonic epithelial cells.
Topics: Adenomatous Polyposis Coli; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Colon; Colonic Neoplasms; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Paclitaxel; Tumor Cells, Cultured | 1999 |